
Please try another search
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
Name | Age | Since | Title |
---|---|---|---|
Kei Ling Li | 76 | 1995 | Co-Founder & Executive Chairman |
Yung Lai Hung | 81 | 1995 | Co-Founder & Executive Director |
Tung Sing Lo | 56 | 2010 | Independent Non-Executive Director |
Hao Xi Ede | 66 | 2015 | Independent Non-Executive Director |
Hong Man Leung | 51 | 2005 | Non-Executive Director |
Ming Yee Lam | 57 | 2018 | Independent Non-Executive Director |
Shuo Hu | 49 | 2025 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review